Relmada Therapeutics's top three insider shareholders as of September 29, 2026 are Sergio Traversa (Chief Executive Officer, 1.50Mn shares), Maged Shenouda (Chief Financial Officer, 1.00Mn shares), Paul Edward Kelly (Chief Operating Officer, 502.30K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Sergio Traversa | Chief Executive Officer | 1,500,000 | 0 | 1,500,000 | 43.9% | 11 Sep, 2026 |
| 2 | Maged Shenouda | Chief Financial Officer | 1,000,000 | 0 | 1,000,000 | 29.3% | 11 Sep, 2026 |
| 3 | Paul Edward Kelly | Chief Operating Officer | 502,295 | 0 | 502,295 | 14.7% | 06 Nov, 2025 |
| 4 | Chuck Ence | Cao And Coo | 403,931 | 0 | 403,931 | 11.8% | 06 Nov, 2025 |
| 5 | Cedric O'Gorman | Chief Medical Officer | 10,121 | 0 | 10,121 | 0.3% | 24 May, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 09 Sep, 2026 | Sergio Traversa | Chief Executive Officer | Acquired P | 100,000 | $4.18 | $418.00K | 1,400,000 | Direct |
| 09 Sep, 2026 | Maged Shenouda | Chief Financial Officer | Acquired P | 120,200 | $4.20 | $504.84K | 920,200 | Direct |
| 10 Sep, 2026 | Sergio Traversa | Chief Executive Officer | Acquired P | 100,000 | $4.10 | $410.00K | 1,500,000 | Direct |
| 10 Sep, 2026 | Maged Shenouda | Chief Financial Officer | Acquired P | 79,800 | $4.25 | $339.15K | 1,000,000 | Direct |
| 15 Dec, 2025 | Maged Shenouda | Chief Financial Officer | Acquired P | 11,665 | $4.12 | $48.06K | 800,000 | Direct |
| 12 Dec, 2025 | Charles J Casamento | Director | Acquired A | 164,000 | $0.00 | $0 | 164,000 | Direct |
| 15 Dec, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 27,500 | $4.12 | $113.30K | 1,300,000 | Direct |
| 12 Dec, 2025 | Chuck Ence | Ca And Co | Acquired A | 828,000 | $0.00 | $0 | 828,000 | Direct |
| 12 Dec, 2025 | John Glasspool | Director | Acquired A | 164,000 | $0.00 | $0 | 164,000 | Direct |
| 12 Dec, 2025 | Fabiana Fedeli | Director | Acquired A | 164,000 | $0.00 | $0 | 164,000 | Direct |
| 12 Dec, 2025 | Paul Edward Kelly | Coo | Acquired A | 828,000 | $0.00 | $0 | 828,000 | Direct |
| 12 Dec, 2025 | Sergio Traversa | Chief Executive Officer | Acquired A | 1,198,000 | $0.00 | $0 | 1,198,000 | Direct |
| 12 Dec, 2025 | Maged Shenouda | Chief Financial Officer | Acquired A | 828,000 | $0.00 | $0 | 828,000 | Direct |
| 05 Nov, 2025 | Maged Shenouda | Chief Financial Officer | Acquired P | 500,000 | $2.20 | $1.10Mn | 788,335 | Direct |
| 05 Nov, 2025 | Paul Edward Kelly | Chief Operating Officer | Acquired P | 90,000 | $2.20 | $198.00K | 502,295 | Direct |
| 05 Nov, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 272,500 | $2.20 | $599.50K | 1,272,500 | Direct |
| 05 Nov, 2025 | Chuck Ence | Cao And Coo | Acquired P | 136,000 | $2.20 | $299.20K | 403,931 | Direct |
| 26 Aug, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 80,545 | $0.62 | $49.94K | 814,569 | Direct |
| 27 Aug, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 129,455 | $0.67 | $86.73K | 944,024 | Direct |
| 28 Aug, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 55,976 | $0.74 | $41.42K | 1,000,000 | Direct |